Dialysis is associated with an increased generation of oxidants, which play
an important part in the development of endothelial dysfunction and athero
genesis. Markers of oxidative stress include F2-isoprostanes and ethane. Me
asurements in dialysis patients before dialysis showed higher levels of est
erified plasma F2-isoprostanes (1.62 +/- 0.73 ng/mL) than in control subjec
ts (0.27 +/- 0.10 ng/mL) (P < 0.001). Furthermore, levels also correlated w
ith high plasma C-reactive protein (CRP) levels (r = .48, P = 0.015). Breat
h ethane levels for dialysis patients (N = 19) were 6.32 +/- 3.16 pmol/kg-m
in, in contrast to 3.08 +/- 1.50 pmol/kg-min in control subjects (N = 11, P
< 0.005). Analysis to investigate the relationship between CRP levels and
outcome indicated that there was a significant difference in mortality rate
over a 3-year period between patients with low and high CRP values (P < 0.
001). Patients with high CRP (> 16.8 mg/L) levels were more than twice as l
ikely to die as patients with low CRP levels (relative risk [RR] = 2.16; 95
% confidence interval [CI], 1.50-3.09). CRP values were a significant predi
ctor of mortality even after controlling for diabetes, albumin, ferritin, a
nd age at commencement of dialysis. The FIR for CRP after adjustment was 1.
58 (95% Cl, 1.06-2.34, P = 0.024). There were no significant interactions b
etween CRP and other predictors of mortality, indicating that high CRP leve
ls have an additive effect on the mortality risk. These findings show that
hemodialysis patients are exposed to both oxidative stress and inflammation
. (C) 2001 by the National Kidney Foundation, Inc.